HIGHLIGHTS
- who: G. Nogueira-Costa md and colleagues from the (UNIVERSITY) have published the research: Prognostic utility of neutrophil-to-lymphocyte ratio in patients with metastatic colorectal cancer treated using different modalities, in the Journal: (JOURNAL) of 28/02/2019
- what: The authors compared real-world survival for patients with mcrc based on their nlr group, and the authors assessed the utility of the nlr in determining first-line chemotherapy and metastasectomy benefit. A possible explanation for the difference is that, in the study , the authors used a roc estimation to determine the nlr cut-off . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.